kolitics t1_j5wcgie wrote
Reply to comment by shiruken in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
Assuming the remaining 52% is coming from mutation and not time since booster or other factors.
Viewing a single comment thread. View all comments